Rise and Shine: What you need to know before the ASX opens
Link copied to
But first, here’s what you need to know right now:
The Australian Bureau of Statistics will drop figures on employment in renewable energy activities today.
China today releases a March data deluge, with fixed asset investment and industrial production numbers, along with retail sales and Q1 GDP (forecast annual growth of 6.3 per cent).
Carbonxt (ASX:CG1) has 12.8 million shares coming out of escrow today.
The following 11 companies have shares due out of a trading halt in the next 48 hours:
Gold: $US1,278.03 ($1,781.19) -0.86%
Silver: $US14.99 +0.03%
Oil (Brent): $US71.69 +0.90%
Oil (WTI): $US64.27 +0.47%
Coal: $US88.08 +1.09%
Iron ore 62% fe: $US93.97 +0.19%
Want this headstart in your inbox every morning at 8am? Go on. Subscribe here. It’s free
Can small cap tech companies do math? That’s the question we were all asking ourselves on the Stockhead Facebook chat forum, after both Dragontail Systems (ASX:DTS) and Pointerra (ASX:3DP) appeared to struggle with percentage calculations in their quarterly announcements.
These were the five most-discussed stocks on trading gossip forum HotCopper at close on yesterday:
— HotCopper (@HotCopper) April 16, 2019
Tuesday April 16 will go down as a hell of a day for a select group of small caps.
Property tech company Assetowl Limited (ASX:AO1) caught the market’s attention, posting a lazy 225 per cent gain to 2.6 cents.
It followed an announcement that listed real estate agency The Agency Group Australia Ltd (ASX:AU1) will carry out a trial of Assetowl’s Inspector360 platform as part of its service offering.
The aim of the platform is to improve the real estate inspection process by providing 360-degree imagery, videos and hotspot mapping at individual properties.
Fintech Chain (ASX:FTC) rocketed 133 per cent to 14c on news that it has helped facilitate $83.4 million in transactions on its partner China Merchants Bank’ network on a limited trial basis in four selected Chinese provinces.
Cancer fighting company Noxopharm Ltd (ASX:NOX) jumped 44 per cent to 54c after an update on its anti-cancer medication.
Pre-clinical trials showed that Idronoxil, the key component of the drug, “activates cells associated with both the innate and adaptive immune systems, increasing functional natural killer (NK) cells and CD4+ (T-helper) cell numbers”, the company said.
Eclipse Uranium (ASX:EPM) had a rough day, falling by more than 30 per cent to 0.2 cents. Late last week, the company announced it had increased the size of its exploration area at the Ngalia Basin site in the Northern Territory.
That’s all you need to know. Go go go!